HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

The Cruelty Free Cosmetics Resolution passes the California Assembly, aimed at driving congressional support for a federal ban on animal-tested cosmetics and cosmetic ingredients. In other news, Avon and Elizabeth Arden announce cost-cutting initiatives.

You may also be interested in...



People In Brief

CFSAN announces its new director, with Michael Landa stepping down in January 2015. Avon is taking a new approach to management in its largest market, Latin America.

Declining Celeb-Scent Sales Sink Elizabeth Arden In FY 2014

Elizabeth Arden’s fourth-quarter and full-year sales nosedived 28% and 13.4%, respectively, with sales of Taylor Swift and Justin Bieber fragrances down. Separately, the firm announces that it has received a $50 million investment from private-equity firm Rhone Capital in exchange for 7.6% of its outstanding common stock.

In Brief: California Seeks Federal Animal-Test Ban; PCPC Unveils GMPs Aid; More

A joint resolution approved by California’s State Senate calls for a federal ban on cosmetic animal testing; The Personal Care Products Council introduces a new tool companies can use to verify Good Manufacturing Compliance conformance. More news in brief.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019092

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel